HealthJohnson & Johnson Reports Early JNJ-6143 Responses in Prostate Cancer TrialBy Naomi CalderOct 24, 2026, 6:21 PM UTC
HealthStudy Links Apalutamide Before and After Surgery to Lower Event HazardBy Naomi CalderOct 24, 2026, 3:21 PM UTC
HealthTrial Links Darolutamide Add-On to 95% Four-Year Metastasis-Free SurvivalBy Naomi CalderOct 24, 2026, 11:40 AM UTC
HealthUCLA's MAESTRO AI Flags a Drug Pairing in Prostate Cancer Cell ModelsBy Naomi CalderOct 23, 2026, 1:54 AM UTC
